Found 109 matching trials
Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients PHASE3 The current study is a multicentre, randomized,double-blind, prospective cl...
Show More Location
The First Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
ATAC - Pharmacokinetics (PK) Sub-Protocol PHASE3 To assess the effect of ARIMIDEX on the pharmacokinetics of tamoxifen and t...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study PHASE2 This study is being carried out to see if ZD1839 is effective in treating m...
Show More Learn More & Join Trial
Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy PHASE4 This study is a double-blind placebo-controlled trial evaluating the effica...
Show More Location
Tuen Mun Hospital
Learn More & Join Trial
Raloxifene for Women With Alzheimer's Disease PHASE2 This is a multisite pilot randomized trial of raloxifene or placebo for the...
Show More Location
Kaiser Permanente Santa Rosa
Learn More & Join Trial
Pulmonary Hypertension and Anastrozole Trial PHASE2 The primary objectives of this study are to determine whether the study dru...
Show More Location
Stanford University
Learn More & Join Trial
A Pilot Clinical Trial With Tocotrienol on Breast Cancer NA Tocotrienol Rich Fraction (TRF) in combination with Tamoxifen will improve ...
Show More Location
Malaysian Palm Oil Board
Learn More & Join Trial
Tamoxifen for the Prevention of Breast Cancer in High-Risk Women PHASE3 The International Breast Cancer Intervention Study I (IBIS-I) was designed ...
Show More Location
Queen Mary University of London
Learn More & Join Trial
Long Term Effects of Raloxifene Treatment on Bone Quality PHASE4 This is a cross-sectional study to determine, via iliac crest bone biopsies...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia PHASE2 SRD5A2 is a critical enzyme for prostatic development and growth, and the S...
Show More Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial